HDAC9 and ichthyosis prematurity syndrome: In a lung model of pulmonary inflammation known as idiopathic pneumonia syndrome (IPS), an HDAC inhibitor induced L-kynurenine and suppressed IL-17 and IL-6 expression, and these damage-related responses were reversed after treatment with the AhR antagonist CH223191 [80].